"Saint Joseph Mercy Health System (SJMHS) is a health care organization serving seven counties in southeast Michigan including Livingston, Washtenaw, Wayne, Oakland, Macomb, Jackson, and Lenawee. It includes 548-bed St. Joseph Mercy Ann Arbor, 497-bed St. Joseph Mercy Oakland in Pontiac, 304-bed St. Mary Mercy Livonia, 66-bed St. Joseph Mercy Livingston in Howell, and 133-bed St. Joseph Mercy Chelsea."

During the past decade, Saint Joseph Mercy Oakland conducted 168 clinical trials. In the 10-year time frame, 168 clinical trials started and 260 clinical trials were completed, i.e. on average, 154.8% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 104 clinical trials were completed. i.e. 167.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Mercy Oakland" #1 sponsor was "National Cancer Institute (NCI)" with 164 trials, followed by "Alliance for Clinical Trials in Oncology" with 92 trials sponsored, "SWOG Cancer Research Network" with 74 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 23 trials sponsored and "NRG Oncology" with 23 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Mercy Oakland" #1 collaborator was "National Cancer Institute (NCI)" with 257 trials as a collaborator, "NRG Oncology" with 47 trials as a collaborator, "Cancer and Leukemia Group B" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 11 trials as a collaborator and "NCIC Clinical Trials Group" with 10 trials as a collaborator. Other collaborators include 89 different institutions and companies that were collaborators in the rest 52 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Mercy Oakland" are "Breast Cancer" (37 trials), "Lung Cancer" (25 trials), "Lymphoma" (13 trials), "Prostate Cancer" (13 trials) and "Recurrent Breast Carcinoma" (13 trials). Many other conditions were trialed in "Saint Joseph Mercy Oakland" in a lesser frequency.

Most popular intervention types in "Saint Joseph Mercy Oakland" are "Drug" (356 trials), "Other" (232 trials), "Biological" (147 trials), "Procedure" (72 trials) and "Radiation" (60 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (108 trials), "Quality-of-Life Assessment" (73 trials), "Paclitaxel" (47 trials), "Carboplatin" (39 trials) and "Questionnaire Administration" (39 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Mercy Oakland" are 348 trials for "All" genders, 88 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Mercy Oakland". undefined are not yet recruiting, 61 are recruiting, 140 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 214 completed trials in Saint Joseph Mercy Oakland, 6 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Mercy Oakland, 17 "Phase 1" clinical trials were conducted, 226 "Phase 2" clinical trials and 195 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 24 trials that are defined as “Not Applicable".